Roivant Sciences Ltd annual free cash flow for fiscal TTM was -$821 million, a decrease of 8.2% from -$759 million in fiscal 2026. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($821M) | ($759M) | ($844M) | ($767M) | ($856M) | ($695M) | ($558M) | ($767M) | ($1.0B) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($271M) | ($165M) | ($201M) | ($194M) | ($208M) | ($173M) | ($209M) | ($268M) | ($268M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ROIV metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All ROIV financial statements → Interactive ROIV charts →
About TickerBase · Data methodology & sources · Privacy · Terms